20/02/2024
Trunerox, which was developed by the Canadian biopharmaceutical Avicanna, is a proprietary oral formulation of 10% cannabidiol, or CBD. https://buff.ly/49lTRpq
Dravet Syndrome News is a digital news publication dedicated to offering comprehensive daily news coverage of Dravet Syndrome.
(3)
Trunerox, which was developed by the Canadian biopharmaceutical Avicanna, is a proprietary oral formulation of 10% cannabidiol, or CBD. https://buff.ly/49lTRpq
As columnist Meagan Cheney's son is evaluated for ADHD, he raises questions about disability, given his sister's experiences with Dravet. https://buff.ly/49CpqLi
Encoded Therapeutics is now cleared to launch Phase 1/2 clinical trials of the Dravet syndrome gene therapy ETX101 in the U.S. and Australia. https://buff.ly/3uELPbV
International Epilepsy Day this Feb. 12 aims to promote public understanding of epilepsy to gather support for a 10-year WHO roadmap on care. https://buff.ly/4890k5J
Columnist Meagan Cheney says the staff at her daughter's school has gone above and beyond in preparing for her standardized tests. https://buff.ly/3HKWpkP
An animal model study found Fintepla, an approved add-on therapy for seizure control, may offer an array of other benefits. https://buff.ly/48UOHQP
Fintepla meaningfully lowered seizure frequency over one year in 60% of Dravet syndrome patients treated in a real-world clinical setting. https://buff.ly/3u2WvRA
Columnist Meagan Cheney is rocked by a bad dream that reminds her of the daily seizures her daughter used to have due to Dravet syndrome. https://buff.ly/3vPGVZO
Five young Dravet children treated with add-on Fintepla (fenfluramine) before age 2 showed reasonable safety and lower seizure rates. https://buff.ly/3RZ7EdV
Help connect rare disease communities for more effective advocacy and support for all. Take our survey for a chance to win 1 of 10 $50 Amazon eGift cards: https://bit.ly/3vJk568
Caregivers of Dravet patients in Spain report often turning to treatments like cognitive and physiotherapy, but benefits are not always clear. https://buff.ly/3Sc7H7t
Available treatments aren't enough to fully control seizures for most people with Dravet syndrome, and many experience side effects. https://buff.ly/3S2vKFP
Epidiolex, an approved CBD therapy for seizures in Dravet, may in rare cases cause side effects including clusters of seizures, per a study. https://buff.ly/3RPh3WG
An outing to see Christmas lights is seizure-free for columnist Meagan Cheney's daughter. It was the best Christmas gift ever. https://buff.ly/481V98o
Treatment with a procedure called transcranial static magnetic stimulation led to less seizure activity in a mouse model of Dravet syndrome. https://buff.ly/3GGTXuU
Columnist Meagan Cheney celebrates all her daughter with Dravet has accomplished this year, including being able to read on her own. https://buff.ly/41f5b3t
An update on open-label studies in young Dravet patients finds STK-001 markedly reduces seizure frequency, improves cognition and behavior. https://buff.ly/3t310Lk
The cannabidiol Epidiolex was granted approval in Canada to treat seizures in patients ages 2 and older with Dravet or other epilepsies. https://buff.ly/3RmCmPj
Diacomit helps to control seizures in people with Dravet and with other childhood disorders marked by hard-to-treat seizures, study reports. https://buff.ly/3QNIf6n
Nighttime seizure monitoring devices are frequently used by Dravet caregivers to prevent SUDEP, according to a questionnaire-based study. https://buff.ly/47zAxDG
Columnist Meagan Cheney, who's parenting a child with Dravet syndrome, says the importance of community can't be overstated. https://buff.ly/3FVDzX5
Newer add-on medications for Dravet syndrome reduced seizure frequency in children by at least 50% versus placebos, a review study reported. https://buff.ly/47hqBOY
People with Dravet syndrome due to mutations in the SCN1A gene are often affected by gastrointestinal and eating problems, a new study found. https://buff.ly/3QelQ1U
As columnist Meagan Cheney ventures back into dating life, she's seeing it's different as a single mother of three kids, one with Dravet. https://buff.ly/3Mmj2Pk
Most children with Dravet syndrome are diagnosed before 1 year of age, and about seven months from symptom onset, a caregiver survey finds. https://buff.ly/46ZZpUW
A man in China was diagnosed with Dravet syndrome after an epileptic seizure that severely worsened existing walking and motor difficulties. https://buff.ly/3RHiWFe
Side effects are more than twice as common in people who use cannabidiol (CBD) to treat some forms of epilepsy, including Dravet syndrome. https://buff.ly/3ZuOSP6
Fintepla was found to significantly reduce seizure frequency in pediatric Dravet patients with hard-to-treat seizures in a Phase 3 trial. https://buff.ly/3Zoh4TG
Despite her youngest daughter's Dravet syndrome diagnosis, columnist Megan Cheney is thrilled by the 8-year-old's progress. https://buff.ly/48779G7
Fifty-two patients will be studied to see how safe and well tolerated LP352 is against a placebo and if it reduces how often seizures happen. https://buff.ly/3Z4aqSk
Be the first to know and let us send you an email when Dravet Syndrome News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Patient advocate Liza Bernstein explains how #AWindowIntoRare will highlight what we can learn from each other as members of the #raredisease community. Join #BioNews in an online panel discussion + Q&A on #RareDiseaseDay at 3 p.m. EST Feb 28. Register: https://bit.ly/Bionews_RegisterNow
Patient advocate Liza Bernstein gives some insight into what will be discussed during "A Window Into Rare," our #RareDiseaseDay online panel discussion on Feb. 28. Register for this live event here: https://bit.ly/Bionews_RegisterNow #AWindowIntoRare #BioNews
"I have an understanding of what it feels like to feel isolated and erased": Patient advocate Liza Bernstein is hosting "A Window Into Rare," our #RareDiseaseDay panel discussion on Feb. 28. Register for this live event here: https://bit.ly/Bionews_RegisterNow #AWindowIntoRare #BioNews
Dravet Syndrome News is part of the BioNews family, and 60% of us behind the scenes live with a rare condition. This is why we strive to provide you with trustworthy content, meaningful resources and a safe space. #WeAreRare. We are #BioNews. Learn more: https://bionews.com #RareDiseases #DravetSyndromeNews #DravetSyndrome #livingwithDravetSyndrome #DravetSyndromeCommunity
Want your business to be the top-listed Media Company?